Vivanza Bioscience Peer Comparison

BSE: 530057

₹1.45

₹-0.03 (-2.03%)

As on 09-Nov-2026IST

Market cap

₹6 Cr

Revenue (TTM)

₹72 Cr

P/E Ratio

214.8

P/B Ratio

1.3

Div. Yield

0 %

Edit

	Vivanza Bioscience	Entero Health	Medi-Caps	Maitri Enterprises	Emcure Pharmaceuticals
Market cap (₹ Cr)	6	9,214	26	14	42,042
Revenue (₹ Cr)	72	7,644	16	33	10,234
Net Profit (₹ Cr)	0.03	191.80	-0.05	1.27	1,092.67
Net Margin (%)	0.04	2.50	-0.22	3.86	10.67
RoE (%)	0.64	8.35	-0.04	23.32	21.65
Price to Earnings	214.81	66.12	--	11.32	38.45
Price-To-Book	1.29	5.18	0.24	2.56	7.87

Income Statement (₹ Cr)

	Vivanza Bioscience	Entero Health	Medi-Caps	Maitri Enterprises	Emcure Pharmaceuticals
Operating Revenue	115.91	6,591.21	12.45	28.66	9,203.54
Total Income	116.02	6,610.45	20.66	28.70	9,335.01
Total Expenditure	115.17	6,325.26	21.85	26.49	7,457.80
EBITDA	0.74	265.96	-9.40	2.17	1,745.74
Depreciation	0.02	43.29	1.81	0.07	415.05
EBIT	0.72	222.66	-11.21	2.10	1,330.70
Interest	0.28	54.39	0.02	0.77	143.67
Other Income	0.11	19.24	8.21	0.04	131.47
Exceptional Items	--	-8.18	--	-1.04	-31.35
Profit before Tax	0.54	179.34	-3.02	0.33	1,287.14
Provision for Tax	0.15	33.50	0.01	0.16	345.87
Profit after Tax	0.39	145.84	-3.04	0.17	941.27

	Vivanza Bioscience	Entero Health	Medi-Caps	Maitri Enterprises	Emcure Pharmaceuticals
Shareholder's Funds	4.36	1,688.61	111.61	4.70	4,950.03
Minority Interest	--	63.94	--	--	26.64
Non-Current Liabilities	0.88	206.12	1.14	3.85	584.19
Current Liabilities	16.85	1,587.57	2.71	7.70	3,912.24
Total Liabilities	22.09	3,600.22	115.46	16.36	9,514.48

	Vivanza Bioscience	Entero Health	Medi-Caps	Maitri Enterprises	Emcure Pharmaceuticals
Non-Current Assets	3.03	1,037.80	68.44	4.05	3,861.01
Current Assets	19.05	2,503.13	47.02	12.19	5,612.10
Total Assets	22.09	3,600.22	115.46	16.36	9,514.48
Total Debt*	10.19	566.68	0.00	6.89	1,204.08
Net Current Assets	2.20	915.56	44.31	4.49	1,699.86
Contingent Liabilities	--	5.51	--	1.79	258.92

	Vivanza Bioscience	Entero Health	Medi-Caps	Maitri Enterprises	Emcure Pharmaceuticals
Cash From Operating Activities	-2.58	96.20	-7.02	3.04	943.55
Cash Flow from Investing Activities	-0.12	-303.06	7.11	1.23	-1,193.06
Cash from Financing Activities	2.65	123.66	--	-4.40	343.43
Net Cash Inflow / Outflow	-0.05	-83.20	0.09	-0.12	93.92

	Vivanza Bioscience	Entero Health	Medi-Caps	Maitri Enterprises	Emcure Pharmaceuticals
ROCE (%)	6.09	10.93	-2.58	8.25	25.25
ROE (%)	9.48	8.57	-2.61	3.66	20.09
ROA (%)	2.05	4.68	-2.52	0.89	10.70
EBIT Margin (%)	0.73	4.33	-9.59	7.74	20.40
Net Margin (%)	0.34	2.21	-14.70	0.59	10.08
Cash Profit Margin (%)	0.36	2.87	-9.88	0.85	14.44

	Vivanza Bioscience	Entero Health	Medi-Caps	Maitri Enterprises	Emcure Pharmaceuticals
Revenue Growth (%)	1,461.44	29.35	-51.14	50.74	16.56
EBIT Growth (%)	388.93	35.13	-229.03	487.36	21.77
Net Profit Growth (%)	158.51	35.75	-431.96	137.55	33.05
EPS Growth (%)	158.52	21.32	-431.95	139.47	35.59
Book Value Growth (%)	9.95	-2.19	-7.97	3.93	11.36

	Vivanza Bioscience	Entero Health	Medi-Caps	Maitri Enterprises	Emcure Pharmaceuticals
Price / Earnings	17.85	47.12	0.00	64.91	32.73
Price / Book Value	1.62	3.22	0.26	2.45	6.13
Dividend Yield (%)	0.00	0.00	0.00	0.00	0.23
EV/EBITDA	20.23	20.43	-23.82	8.11	16.68
Market Cap (₹ Cr)	7.04	5,420.61	28.93	11.52	30,257.56

	Vivanza Bioscience	Entero Health	Medi-Caps	Maitri Enterprises	Emcure Pharmaceuticals
Debt to Equity	2.34	0.34	0.00	1.47	0.24
Short term debt to equity ratio	2.14	0.26	--	0.62	0.16
Current Ratio	1.13	1.58	17.34	1.58	1.43
Quick Ratio	0.92	1.05	16.26	0.84	0.82
Interest Coverage	2.92	4.30	-137.05	1.43	9.96

	Vivanza Bioscience	Entero Health	Medi-Caps	Maitri Enterprises	Emcure Pharmaceuticals
Debtors to sales (%)	10.68	18.39	55.60	18.89	27.84
Asset Turnover	6.02	2.11	0.10	1.52	1.07
Receivable days	32.19	56.56	230.34	90.06	88.68
Inventory Days	9.15	41.57	90.05	77.78	84.11
Payable days	15.65	34.66	71.74	86.82	176.65
Cash Conversion Cycle	25.69	63.47	248.65	81.03	-3.86

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.